CHERRY SE (C3RY.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:C3RY • DE000A3CRRN9

0.556 EUR
-0.03 (-4.47%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, C3RY scores 2 out of 10 in our fundamental rating. C3RY was compared to 33 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and financial health of C3RY have multiple concerns. C3RY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year C3RY has reported negative net income.
  • In the past year C3RY has reported a negative cash flow from operations.
  • C3RY had negative earnings in 4 of the past 5 years.
  • Of the past 5 years C3RY 4 years had a positive operating cash flow.
C3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFC3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • C3RY has a Return On Assets of -39.96%. This is amonst the worse of the industry: C3RY underperforms 93.94% of its industry peers.
  • C3RY has a Return On Equity of -92.41%. This is in the lower half of the industry: C3RY underperforms 78.79% of its industry peers.
Industry RankSector Rank
ROA -39.96%
ROE -92.41%
ROIC N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
C3RY.DE Yearly ROA, ROE, ROICC3RY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of C3RY (8.78%) is worse than 90.91% of its industry peers.
  • C3RY's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for C3RY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
C3RY.DE Yearly Profit, Operating, Gross MarginsC3RY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • C3RY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • C3RY has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for C3RY has been reduced compared to a year ago.
C3RY.DE Yearly Shares OutstandingC3RY.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
C3RY.DE Yearly Total Debt VS Total AssetsC3RY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • C3RY has an Altman-Z score of -2.46. This is a bad value and indicates that C3RY is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -2.46, C3RY is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.59 indicates that C3RY is somewhat dependend on debt financing.
  • C3RY's Debt to Equity ratio of 0.59 is in line compared to the rest of the industry. C3RY outperforms 42.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z -2.46
ROIC/WACCN/A
WACC4.92%
C3RY.DE Yearly LT Debt VS Equity VS FCFC3RY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • C3RY has a Current Ratio of 1.99. This is a normal value and indicates that C3RY is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.99, C3RY is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • C3RY has a Quick Ratio of 1.99. This is a bad value and indicates that C3RY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • C3RY's Quick ratio of 0.85 is on the low side compared to the rest of the industry. C3RY is outperformed by 69.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 0.85
C3RY.DE Yearly Current Assets VS Current LiabilitesC3RY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • C3RY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.81%, which is quite impressive.
  • C3RY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.62%.
  • The Revenue for C3RY have been decreasing by -13.14% on average. This is quite bad
EPS 1Y (TTM)58.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
Revenue 1Y (TTM)-20.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%8.94%

3.2 Future

  • C3RY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.61% yearly.
  • Based on estimates for the next years, C3RY will show a small growth in Revenue. The Revenue will grow by 2.13% on average per year.
EPS Next Y-26.94%
EPS Next 2Y27.32%
EPS Next 3Y25.61%
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-3.24%
Revenue Next 3Y0.19%
Revenue Next 5Y2.13%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
C3RY.DE Yearly Revenue VS EstimatesC3RY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
C3RY.DE Yearly EPS VS EstimatesC3RY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for C3RY. In the last year negative earnings were reported.
  • Also next year C3RY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
C3RY.DE Price Earnings VS Forward Price EarningsC3RY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
C3RY.DE Per share dataC3RY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • C3RY's earnings are expected to grow with 25.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.32%
EPS Next 3Y25.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • C3RY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHERRY SE

FRA:C3RY (2/6/2026, 7:00:00 PM)

0.556

-0.03 (-4.47%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-14
Earnings (Next)N/A
Inst Owners32.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.51M
Revenue(TTM)96.91M
Net Income(TTM)-52.02M
Analysts44
Price Target0.66 (18.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-32.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-159.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB 4.45
EV/EBITDA N/A
EPS(TTM)-2.21
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS3.99
BVpS2.32
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.96%
ROE -92.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.78%
FCFM N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.21%
Cap/Sales 6.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 0.85
Altman-Z -2.46
F-Score4
WACC4.92%
ROIC/WACCN/A
Cap/Depr(3y)17.41%
Cap/Depr(5y)38.92%
Cap/Sales(3y)6.91%
Cap/Sales(5y)6.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
EPS Next Y-26.94%
EPS Next 2Y27.32%
EPS Next 3Y25.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%8.94%
Revenue Next Year-11.95%
Revenue Next 2Y-3.24%
Revenue Next 3Y0.19%
Revenue Next 5Y2.13%
EBIT growth 1Y34.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8%
EBIT Next 3Y44.3%
EBIT Next 5YN/A
FCF growth 1Y76.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.89%
OCF growth 3Y-28.61%
OCF growth 5YN/A

CHERRY SE / C3RY.DE FAQ

What is the ChartMill fundamental rating of CHERRY SE (C3RY.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to C3RY.DE.


What is the valuation status of CHERRY SE (C3RY.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to CHERRY SE (C3RY.DE). This can be considered as Overvalued.


Can you provide the profitability details for CHERRY SE?

CHERRY SE (C3RY.DE) has a profitability rating of 1 / 10.


What is the expected EPS growth for CHERRY SE (C3RY.DE) stock?

The Earnings per Share (EPS) of CHERRY SE (C3RY.DE) is expected to decline by -26.94% in the next year.